The United States of America

  • Y. Alyssa Kim
  • Robert A. Schwartz


Dermatology in the United States is a dynamic field, largely due to the constant influx of newly arriving immigrants. These immigrants bring their endemic diseases with them, which changes the spectrum of the dermatologic diseases seen in the United States. For this reason, dermatologists practicing in the United States, especially in the large metropolitan cities where new immigrants tend to settle, need to be alert and to adapt to the changing trends of the dermatologic diseases as the medical field is influenced by immigrant populations.


Trypanosoma Cruzi Orange County Leprosy Patient Lepromatous Leprosy Lymphogranuloma Venereum 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    US Department of Justice, Immigration and Naturalization Service. Immigration statistics: fiscal year 1990. Washington, DC: US Government Printing Office, 1991. Available from: Statistics Division, Immigration and Naturalization Service, Washington, DC 20536.Google Scholar
  2. 2.
    Jenista JA, Chapman D: Medical problems of foreign-born adopted children. Am J Dis Child1987; 141: 298–302.PubMedGoogle Scholar
  3. 3.
    Hansen GA: Undwersogelser angaende spe-dalskhedens arsager. Norsk Mag Laegevid1874; 4: 1–88.Google Scholar
  4. 4.
    Barrett-Connor E: Latent and chronic infections imported from southeast Asia. JAMA 1978; 239:1901–1906.PubMedCrossRefGoogle Scholar
  5. 5.
    Fleischer AB Jr, Maxwell BA, Baird DB, Woosley JT: Hansen’s disease (leprosy): The North Carolina experience. Cutis1990; 45: 427–434.PubMedGoogle Scholar
  6. 6.
    Levis WR, Schuman JS, Friedman SM, Newfield SA: An epidemiologic evaluation of leprosy in New York City. JAMA1982; 247: 3221–3226.PubMedCrossRefGoogle Scholar
  7. 7.
    Morbidity and Mortality Weekly Report, Annual Summary, 1979. Atlanta, Centers for Disease Control, 1980.Google Scholar
  8. 8.
    Abe M, Minagawa F, Yoshi Y, et al: Fluorescent leprosy antibody absorption (FLA-ABS) test for detecting subclinical infection with Mycobacterium leprae. Int J Lepr1980; 48: 101–119.Google Scholar
  9. 9.
    Chakravatti MR, Vogel FA: A twin study on leprosy. In: Baker PE, ed: Topics in Human Genetics. Vol. 1. Stuttgart: Georg Thieme Verlag, 1978: 1–23.Google Scholar
  10. 10.
    Kluth FC: Leprosy in Texas: Risk of contacting the disease in the household. Texas Med1956; 52: 785–789.Google Scholar
  11. IL Bucci F, Jr, Mesa M, Schwartz RA, McNeil G, Lambert WC: Oral lesions in lepromatous leprosy. J Med1987; 42: 4–6.Google Scholar
  12. 12.
    Janniger CK, Kapila R, Schwartz RA, et al: Histoid lepromas of lepromatous leprosy. Inf J Dermatol1990; 29: 494–496.CrossRefGoogle Scholar
  13. 13.
    Filice GA, Fräser DW: Management of household contacts of leprosy patients. Ann Intern Med1978; 88: 538–542.PubMedGoogle Scholar
  14. 14.
    Shepard CC, Levy L, Fasal P: Further experience with the rapid bactericidal effect of rifampin on Mycobacterium leprae. Am J Trop Med Hyg1974; 23: 1120–1124.PubMedGoogle Scholar
  15. 15.
    Shepard CC, Levy L, Fasal P: Rapid bactericidal effect of rifampin on M. leprae. Am J Trop Med Hyg1972; 21: 446–449.PubMedGoogle Scholar
  16. 16.
    Levy L, Shepard CC, Fasal P: The bactericidal effect of rifampicin on M. leprae in man: (a) Single doses of 600, 900 and 1,200 mg; and (b) daily doses of 300 mg. Int J Lepr1976; 44: 183–187.Google Scholar
  17. 17.
    Shepard CC, Ellard GA, Levy L, et al: Experimental chemotherapy in leprosy. Bull WHO1976; 53: 425–433.Google Scholar
  18. 18.
    Goens JL, Schwartz RA, De Wolf K: Mucocutaneous manifestations of selected sexually transmitted diseases: chancroid, lymphogranuloma venereum, and granuloma inguinale. Am Fam Phys 1994; 49:415–18, 423–25.Google Scholar
  19. 19.
    Faro S: Lymphogranuloma venereum, chancroid and granuloma inguinale. Obstet Gynecol Clin N Am1988; 10: 517–520.Google Scholar
  20. 20.
    Boyd AS: Clinical efficacy of antimicrobial therapy in Haemophilus ducreyi infections. Arch Dermatol1989; 125: 1399–1405.PubMedCrossRefGoogle Scholar
  21. 21.
    Fiumara NJ, Rothman K, Tang S: The diagnosis and treatment of chancroid. J Am Acad Dermatol1986; 15: 939–943.PubMedCrossRefGoogle Scholar
  22. 22.
    Blackmore CA, Limpakarnjanarat K, Rigua- Perez JG, et al: An outbreak of chancroid in Orange County, California: descriptive epidemiology and disease-control measures. J Infect Dis1985; 151: 840–844.CrossRefGoogle Scholar
  23. 23.
    Chancroid—Massachusetts. MMWR1985; 34: 711–718.Google Scholar
  24. 24.
    Becker TM, De Witt W, Van Dusen G: Hae-mophilas ducreyi infection in south Florida: a rare disease on the rise? South Med J1987; 80: 182–184.PubMedCrossRefGoogle Scholar
  25. 25.
    Sexually transmitted disease statistics. Atlanta, GA: Centers for Disease Control, 1987:2,37. Publication 136.Google Scholar
  26. 26.
    McCarley ME PD, Jr, Sontheimer RD: Chancroid: clinical variants and other findings from an epidemic in Dallas County, 1986–1987. J Am Acad Dermatol1988; 19: 330–337.PubMedCrossRefGoogle Scholar
  27. 27.
    Schmid GP, Sanders LL, Jr, Blount JH, Alexander ER: Chancroid in the United States: reestablishment of an old disease. JAMA1987; 258: 3265–3268.PubMedCrossRefGoogle Scholar
  28. 28.
    Khoo R, Sng EN, Goh AJ: A study of sexually transmitted diseases in 200 prostitutes in Singapore. Asia J Infect Dis1977; 1: 72–79.Google Scholar
  29. 29.
    Schmid GP: Treatment of chancroid, 1989. Rev Infect Dis1990; 12(suppl 6): 5580–5589.CrossRefGoogle Scholar
  30. 30.
    Richman TB, Kerdel FA: Amebiasis and trypanosomiasis. Dermatol Clin1989; 7; 301–311.PubMedGoogle Scholar
  31. 31.
    Woody NC, Woody HB: American trypanosomiasis (Chagas’ disease). First indigenous case in the U.S.A. JAMA1955; 159: 676–677.Google Scholar
  32. 32.
    Greer DA: Found: Two cases of Chagas’ disease. Texas Health Bull1955; 9: 11–13.Google Scholar
  33. 33.
    Schiffler RJ, Mansur GP, Navin TR, Limpa-karnjanaat K: Indigenous Chagas’ disease (American trypanosomiasis) in California. JAMA1984; 251: 2983–2984.PubMedCrossRefGoogle Scholar
  34. 34.
    Kirchhoff LV, Neva FA: Chagas’ disease in Latin American immigrants. JAMA1985; 254: 3058–3060.PubMedCrossRefGoogle Scholar
  35. 35.
    Kirchhoff LV: Is Trypanosoma cruzi a new threat to our blood supply? Ann Intern Med1989; 111: 773–774.PubMedGoogle Scholar
  36. 36.
    Kirchhoff LV, Giam AA, Gilliam FC: American Trypanosomiasis (Chagas“ disease) in Central American immigrants. Am J Med1987; 82: 915–920.PubMedCrossRefGoogle Scholar
  37. 3777.
    Kerndt P, Waskih M, Shulman T, et al: Trypanosomia cruzi antibody among blood donors in Los Angeles, California. Transfusion 1988; 28{suppl):315.Google Scholar
  38. 38.
    Grant IH, Gold JW, Wittner M, et al: Transfusion-associated acute Chagas’ disease acquired in the U.S.A. Ann Intern Med1989; 111: 849–851.PubMedGoogle Scholar
  39. 39.
    Geiseler PJ, Ito II, Kerndt PR, et al: Program & Abstracts: Twenty-seventh Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington D.C.: American Society for Microbiology, 1987: 169.Google Scholar
  40. 40.
    Nickerson P, Orr P, Schroeder ML, et al: Transfusion-associated Trypanosoma cruzi infection in a non-endemic area. Ann Intern Med1989; 111: 851–853.PubMedGoogle Scholar
  41. 41.
    Hagar JM, Rahimtoola M: Chagas’ heart disease in the United States. N Engl J Med 1991: 325:763–768.PubMedCrossRefGoogle Scholar
  42. 42.
    Wortman PD: Subcutaneous cysticercosis. J Am Acad Dermatol1991; 25: 409–414.PubMedCrossRefGoogle Scholar
  43. 43.
    Schlossberg D, Mader IT: Cysticercus cellulosae cutis. Arch Dermatol1978: 114: 459–460.PubMedCrossRefGoogle Scholar
  44. 44.
    King DT, Gilbert DJ, Gurevitch AW, et al: Subcutaneous cysticercosis. Arch Dermatol1979; 115: 236.PubMedCrossRefGoogle Scholar
  45. 45.
    Raimer S, Wolf JE, Jr: Subcutaneous cysticercosis. Arch Dermatol1978; 114: 107–108.PubMedCrossRefGoogle Scholar
  46. 46.
    Tschen EH, Tschen EA, Smith GB: Cutaneous cysticercosis treated with metrifonate. Arch Dermatol1981; 117: 507–509.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag New York, Inc. 1994

Authors and Affiliations

  • Y. Alyssa Kim
  • Robert A. Schwartz

There are no affiliations available

Personalised recommendations